{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:47:18Z","timestamp":1784011638749,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10620-025-09180-y","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:35:19Z","timestamp":1751362519000},"page":"3465-3475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-5877","authenticated-orcid":false,"given":"Angela J.","family":"Forbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0603-5661","authenticated-orcid":false,"given":"Chris M. A.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-7386","authenticated-orcid":false,"given":"Andrew S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2298-5141","authenticated-orcid":false,"given":"Richard B.","family":"Gearry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"9180_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205\u2013217.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"9180_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/gutjnl-2017-315568","volume":"68","author":"J Burisch","year":"2019","unstructured":"Burisch J, Kiudelis G, Kupcinskas L et al. Natural disease course of Crohn\u2019s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 2019;68:423\u2013433.","journal-title":"Gut."},{"key":"9180_CR3","doi-asserted-by":"publisher","first-page":"otae040","DOI":"10.1093\/crocol\/otae040","volume":"6","author":"CA Siegel","year":"2024","unstructured":"Siegel CA, Sharma D, Griffith J, Doan Q, Xuan S, Malter L. Treatment pathways in patients with Crohn\u2019s disease and ulcerative colitis: understanding the road to advanced therapy. Crohns Colitis 360. 2024;6:otae040.","journal-title":"Crohns Colitis 360."},{"key":"9180_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","volume":"17","author":"H Gordon","year":"2023","unstructured":"Gordon H, Biancone L, Fiorino G et al. ECCO guidelines on inflammatory bowel disease and malignancies. J Crohns Colitis. 2023;17:827\u2013854.","journal-title":"J Crohns Colitis."},{"key":"9180_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715-730 e713.","journal-title":"Gastroenterology."},{"key":"9180_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.crohns.2014.01.019","volume":"8","author":"AN Ananthakrishnan","year":"2014","unstructured":"Ananthakrishnan AN, Cagan A, Gainer VS et al. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis. 2014;8:956\u2013963.","journal-title":"J Crohns Colitis."},{"key":"9180_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/gutjnl-2018-317572","volume":"69","author":"O Olen","year":"2020","unstructured":"Olen O, Askling J, Sachs MC et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964\u20132014. Gut. 2020;69:453\u2013461.","journal-title":"Gut."},{"key":"9180_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MIB.0000000000000608","volume":"22","author":"A Bitton","year":"2016","unstructured":"Bitton A, Vutcovici M, Sewitch M, Suissa S, Brassard P. Mortality trends in Crohn\u2019s disease and ulcerative colitis: a population-based study in Quebec. Canada. Inflamm Bowel Dis. 2016;22:416\u2013423.","journal-title":"Canada. Inflamm Bowel Dis."},{"key":"9180_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/ecco-jcc\/jjac166","volume":"17","author":"C Dupont-Lucas","year":"2023","unstructured":"Dupont-Lucas C, Leroyer A, Ley D et al. Increased risk of cancer and mortality in a large French population-based paediatric-onset inflammatory bowel disease retrospective cohort. J Crohns Colitis. 2023;17:524\u2013534.","journal-title":"J Crohns Colitis."},{"key":"9180_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/apt.15701","volume":"51","author":"D King","year":"2020","unstructured":"King D, Reulen RC, Thomas T et al. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000\u20132018. Aliment Pharmacol Ther. 2020;51:922\u2013934.","journal-title":"Aliment Pharmacol Ther."},{"key":"9180_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MIB.0b013e31827f27ae","volume":"19","author":"M Bewtra","year":"2013","unstructured":"Bewtra M, Kaiser LM, TenHave T, Lewis JD. Crohn\u2019s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis. 2013;19:599\u2013613.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ibd.21007","volume":"16","author":"D Duricova","year":"2009","unstructured":"Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T. Overall and cause-specific mortality in Crohn\u2019s disease: a meta-analysis of population-based studies. Inflamm Bowel Dis. 2009;16:347\u2013353.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/ecco-jcc\/jjac156","volume":"17","author":"B Follin-Arbelet","year":"2023","unstructured":"Follin-Arbelet B, Cvancarova Smastuen M, Hovde O, Jelsness-Jorgensen LP, Moum B. Mortality in patients with inflammatory bowel disease: results from 30 years of follow-up in a norwegian inception cohort (the IBSEN study). J Crohns Colitis. 2023;17:497\u2013503.","journal-title":"J Crohns Colitis."},{"key":"9180_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ibd\/izae120","volume":"31","author":"KR Nielsen","year":"2024","unstructured":"Nielsen KR, Lophaven SN, Midjord J, Langholz E, Burisch J, Hammer T. Mortality of patients with inflammatory bowel disease in the Faroe Islands from 1966\u20132020. Inflamm Bowel Dis. 2024;31:952.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.mayocp.2018.03.004","volume":"93","author":"S Aniwan","year":"2018","unstructured":"Aniwan S, Harmsen WS, Tremaine WJ, Kane SV, Loftus EV. Overall and cause-specific mortality of inflammatory bowel disease in Olmsted County, Minnesota, from 1970 through 2016. Mayo Clin Proc. 2018;93:1415\u20131422.","journal-title":"Mayo Clin Proc."},{"key":"9180_CR16","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/MIB.0b013e31829ed8a6","volume":"19","author":"CP Selinger","year":"2013","unstructured":"Selinger CP, Andrews J, Dent OF et al. Cause-specific mortality and 30-year relative survival of Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis. 2013;19:1880\u20131888.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/gutjnl-2014-307983","volume":"64","author":"CN Bernstein","year":"2015","unstructured":"Bernstein CN, Nugent Z, Targownik LE, Singh H, Lix LM. Predictors and risks for death in a population-based study of persons with IBD in Manitoba. Gut. 2015;64:1403\u20131411.","journal-title":"Gut."},{"key":"9180_CR18","first-page":"1153","volume":"19","author":"MP Johansen","year":"2024","unstructured":"Johansen MP, Wewer MD, Krarup PM, Burisch J, Nordholm-Carstensen A. Cancer characteristics, prognoses and mortality of colorectal cancer in patients with Crohn\u2019s disease\u2014a Danish nationwide cohort study, 2009\u20132019. J Crohns Colitis. 2024;19:1153.","journal-title":"J Crohns Colitis."},{"key":"9180_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/apt.16677","volume":"55","author":"J Burisch","year":"2022","unstructured":"Burisch J, Lophaven S, Munkholm P, Langholz E. Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962\u20131987 and followed until 2017 in a Danish population-based inception cohort. Aliment Pharmacol Ther. 2022;55:339\u2013349.","journal-title":"Aliment Pharmacol Ther."},{"key":"9180_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1053\/j.gastro.2015.06.001","volume":"149","author":"S Singh","year":"2015","unstructured":"Singh S, Al-Darmaki A, Frolkis AD et al. Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2015;149:928\u2013937.","journal-title":"Gastroenterology."},{"key":"9180_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","volume":"7","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7:107\u2013112.","journal-title":"J Crohns Colitis."},{"key":"9180_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409\u20131422.","journal-title":"Am J Gastroenterol."},{"key":"9180_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1177\/2047487318792952","volume":"25","author":"HH Sun","year":"2018","unstructured":"Sun HH, Tian F. Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis. Eur J Prev Cardiol. 2018;25:1623\u20131631.","journal-title":"Eur J Prev Cardiol."},{"key":"9180_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.crohns.2014.02.015","volume":"8","author":"A Jussila","year":"2014","unstructured":"Jussila A, Virta LJ, Pukkala E, Farkkila MA. Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. J Crohns Colitis. 2014;8:1088\u20131096.","journal-title":"J Crohns Colitis."},{"key":"9180_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1445-5994.1982.tb02443.x","volume":"12","author":"RJ Eason","year":"1982","unstructured":"Eason RJ, Lee SP, Tasman-Jones C. Inflammatory bowel disease in Auckland, New Zealand. Aust N Z J Med. 1982;12:125\u2013131.","journal-title":"Aust N Z J Med."},{"key":"9180_CR26","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/ibd\/izad295","volume":"30","author":"AJ Forbes","year":"2023","unstructured":"Forbes AJ, Frampton CMA, Day AS, Kaplan GG, Gearry RB. The epidemiology of inflammatory bowel disease in oceania: a systematic review and meta-analysis of incidence and prevalence. Inflamm Bowel Dis. 2023;30:2076.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MPG.0000000000003900","volume":"77","author":"AJ Forbes","year":"2023","unstructured":"Forbes AJ, Frampton CMA, Day AS, Vernon-Roberts A, Gearry RB. Descriptive epidemiology of paediatric inflammatory bowel disease in oceania: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2023;77:512.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"9180_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.mib.0000231572.88806.b9","volume":"12","author":"RB Gearry","year":"2006","unstructured":"Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn\u2019s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis. 2006;12:936\u2013943.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR29","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A-36A.","journal-title":"Can J Gastroenterol."},{"key":"9180_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1440-1746.2009.06140.x","volume":"25","author":"RB Gearry","year":"2010","unstructured":"Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325\u2013333.","journal-title":"J Gastroenterol Hepatol."},{"key":"9180_CR31","unstructured":"Health New Zealand Te Whatu Ora. Mortality Collection, 2024. https:\/\/www.tewhatuora.govt.nz\/for-health-professionals\/data-and-statistics\/mortality\/data-web-tool. Accessed November 18, 2024."},{"key":"9180_CR32","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/MIB.0000000000000829","volume":"22","author":"HY Su","year":"2016","unstructured":"Su HY, Gupta V, Day AS, Gearry RB. Rising incidence of inflammatory bowel disease in Canterbury, New Zealand. Inflamm Bowel Dis. 2016;22:2238\u20132244.","journal-title":"Inflamm Bowel Dis."},{"key":"9180_CR33","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/jgh3.70038","volume":"8","author":"AJ Forbes","year":"2024","unstructured":"Forbes AJ, Frampton CMA, Day AS et al. Ten-year outcomes of a prospective population-based incidence cohort of inflammatory bowel disease patients from Canterbury, New Zealand. JGH Open. 2024;8:e70038.","journal-title":"JGH Open."},{"key":"9180_CR34","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1111\/codi.15756","volume":"23","author":"G Gatenby","year":"2021","unstructured":"Gatenby G, Glyn T, Pearson J, Gearry R, Eglinton T. The long-term incidence of dysplasia and colorectal cancer in a Crohn\u2019s colitis population-based cohort. Colorectal Dis. 2021;23:2399\u20132406.","journal-title":"Colorectal Dis."},{"key":"9180_CR35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/ecco-jcc\/jjad155","volume":"18","author":"KR Nielsen","year":"2024","unstructured":"Nielsen KR, Midjord J, Nymand Lophaven S, Langholz E, Hammer T, Burisch J. The incidence and prevalence of inflammatory bowel disease continues to increase in the Faroe Islands\u2014a cohort study from 1960 to 2020. J Crohns Colitis. 2024;18:308\u2013319.","journal-title":"J Crohns Colitis."},{"key":"9180_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/apt.16615","volume":"55","author":"J Burisch","year":"2022","unstructured":"Burisch J, Lophaven S, Langholz E, Munkholm P. The clinical course of Crohn\u2019s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962\u20132017. Aliment Pharmacol Ther. 2022;55:73\u201382.","journal-title":"Aliment Pharmacol Ther."},{"key":"9180_CR37","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.jhepr.2024.101272","volume":"7","author":"KK Leung","year":"2024","unstructured":"Leung KK, Li W, Hansen B et al. Primary sclerosing cholangitis-inflammatory bowel disease: epidemiology, mortality, and impact of diagnostic sequence. JHEP Rep. 2024;7:101272.","journal-title":"JHEP Rep."},{"key":"9180_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","volume":"9","author":"JH Ngu","year":"2011","unstructured":"Ngu JH, Gearry RB, Wright AJ, Stedman CA. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2011;9:1092\u201310971135.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9180_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10620-024-08811-0","volume":"70","author":"AJ Forbes","year":"2025","unstructured":"Forbes AJ, Day AS, Frampton CMA, Gearry RB. Incidence of inflammatory bowel disease in Canterbury, New Zealand, 2018\u20132023. Dig Dis Sci. 2025;70:719. https:\/\/doi.org\/10.1007\/s10620-024-08811-0.","journal-title":"Dig Dis Sci."},{"key":"9180_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18:56\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09180-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:21:37Z","timestamp":1760595697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09180-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9180"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09180-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Angela Forbes has no financial disclosures. Professor Andrew Day\u2019s research is supported by Cure Kids. Professor Chris Frampton has no financial disclosures. Professor Richard Gearry has sat on advisory boards, speaker\u2019s bureaus or received research funding from AbbVie, Janssen, Pharmaco, Takeda, and Zespri.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the University of Otago Human Research Ethics Committee reference number CTY\/03\/01\/011.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}